Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Piramal Enterprises

Piramal Enterprises

BSE: 500302|NSE: PEL|ISIN: INE140A01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 10, 16:00
1449.20
2.8 (0.19%)
VOLUME 55,584
LIVE
NSE
Jul 10, 16:05
1448.85
2.45 (0.17%)
VOLUME 869,140
News on Piramal Enterprises
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Nicholas Piramal, tgt Rs 377: Sharekhan

1.33 pm | 24 Dec 2007 |  Source: Moneycontrol.com

Sharekhan research has maintained buy rating on NIcholas Piramal with target price of Rs 377. Nicholas is discounting its FY2008E earnings by 20.8x an...

Margins to improve from FY09: Nicholas Piramal 

1.02 pm | 20 Dec 2007 |  Source: CNBC-TV18

Speaking to CNBC-TV18, Ajay Piramal, Chairman, Nicholas Piramal said that margins will improve from FY09. He added that the tax liability is seen at 1...

Nicholas Piramal to carry out drug discovery programme  

3.18 pm | 19 Nov 2007 |  Source: Moneycontrol.com

Nicholas Piramal has signed a drug discovery and development pact with Merck and Company for two oncology drugs. The company may get up to USD 175 mil...

Nicholas Piramal signs deal with Merck & Co 

10.41 am | 19 Nov 2007 |  Source: Moneycontrol.com

Nicholas Piramal has announced a drug discovery and development agreement with Merck & Co. The deal has been signed for two Oncology drugs. Nicholas P...

Sorento earns 6 nominations at RX Club Awards

11.31 am | 17 Nov 2007

Sorento Healthcare earns 6 nominations at the 2007 RX Club Awards. Sorento Healthcare is one of the leading healthcare agency in India started a decad...

Four Indian suitors in race to buy Pfizer's Irish unit:Srcs 

2.22 pm | 06 Nov 2007 |  Source: Moneycontrol.com

CNBC-TV18 has learnt that Jubilant, Nicholas Piramal, Dr Reddy's and Dishman are in race to buy Pfizer's Irish unit....

Indian Pharma Industry a continuing success story

1.20 pm | 02 Nov 2007

Indian Pharma Industry a continuing success story...

Punj Lloyds cons net revenues at Rs 3342.66cr up 65.27%

5.54 pm | 01 Nov 2007

Punj Lloyds consolidated net revenues at Rs 3,342.66 crore, up 65.27%. Q2 net profit up by 166.59% to Rs 89.44 crore; operating revenues up 138.38% a...

CII Pharma Summit focusing on growth strategies 

5.09 pm | 01 Nov 2007 |  Source: Moneycontrol.com

The CII pharma summit is underway in Mumbai. The focus of the summit has been on growth strategies for the pharma sector. The summit is trying to capt...

Nicholas revises rev guidance from 25% to 20% for FY08

12.25 pm | 26 Oct 2007 |  Source: Moneycontrol.com

Nicholas Piramal has announced its second quarter earnings. It has posted its consolidated net profit of Rs 84.8 crore for the quarter ended September...

Nicholas Piramal revises down its revenue guidance

5.46 pm | 25 Oct 2007 |  Source: Moneycontrol.com

Nicholas Piramal hasannounced its Q2 FY08 result and organised a conference call to discuss the same and its future guidance....

Nicholas Piramal net up due to rise in custom mftg revenues 

4.23 pm | 25 Oct 2007 |  Source: Moneycontrol.com

Ajay Piramal, Chairman, Nicholas Piramal, said sales growth this quarter is 17% compared to 7% last year. He attributes the jump in profits to rise in...

Nicholas Piramal Q2 net profit at Rs 84.8 cr

1.54 pm | 25 Oct 2007 |  Source: Moneycontrol.com

Nicholas Piramal has announced its second quarter earnings. It has posted its consolidated net profit of Rs 84.8 crore for the quarter ended September...

Bio-Tech strategy to be announced in 2 weeks: Kapil Sibal

12.56 pm | 15 Oct 2007

New Bio-Technology strategy to be announced in two weeks: Kapil Sibal...

Drug cos hiving off R&D units

8.43 am | 15 Oct 2007 |  Source: Business Line

The hived-off new drug research business of Indias top ten pharma companies could independently be worth $120 billion in market cap by 2015, acco...

Nicholas Piramal R&D hive-off to be approved by June 08

1.16 pm | 13 Oct 2007 |  Source: Moneycontrol.com

Commenting on the spinning off of Nicholas Piramal's R&D business, Swati Piramal. Director, Nicholas Piramal said that approvals for the hiving off ar...

Ranbaxy to hive off discovery and research arm 

8.58 am | 11 Sep 2007

A new lease of life for Ranbaxy's discovery research arm is on the cards. Ranbaxy, which has 1200 scientists working in different areas of pharmaceuti...

Ranbaxy to focus on EMs: Malvinder Singh 

11.31 am | 10 Sep 2007

Malvinder Singh, CEO and Managing Director, Ranbaxy Laboratories, said he is confident of securing a 180-day exclusivity for Lipitor in March 2010. Th...

Edelweiss maintains buy on Nicholas Piramal

12.56 pm | 05 Sep 2007

Edelweiss is bullish on Nicholas Piramal and has maintained buy rating on the stock. Research firm believe that the EPS for stock could move up from 1...

Buy Nicholas Piramal with target Rs 326: Sharekhan

9.50 am | 04 Sep 2007

Sharekhan Stock Broking firm is bullish on Nicholas Piramal and has maintained buy rating on the stock with target price of Rs 326....

1 2 3 4
Quick Links for Piramal Enterprises
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.